VivoSeq
Dermatology

Lipoma

8

Pipeline Programs↗

3

Active Trials↗

8

Companies Involved↗

Lipoma is an early-stage landscape with 8 programs across 8 companies. The most active players are AbbVie, Glonova Pharma Co., Ltd, Caliway Biopharmaceuticals Co., Ltd.. 1 therapy is approved.

Intelligence

Pipeline Metrics

Competitive Density

35/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AbbVie logo

AbbVie

2 programs

Phase 1G

Glonova Pharma Co., Ltd

1 program

Phase 1C

Caliway Biopharmaceuticals Co., Ltd.

1 program

Phase 2R

Raziel Therapeutics Ltd.

1 program

Phase 2Endo Pharmaceuticals logo

Endo Pharmaceuticals

1 program

Phase 2P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

10

clinical trials

Completed7 · 70%
Recruiting3 · 30%

Clinical Trials

Trial Activity

10 trials

Intralesional Ronkyla Plus Injection for the Treatment of Superficial Lipoma
Recruiting·GGlonova Pharma Co., Ltd·Phase 1·NCT07237425·56 enrolled
A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas
Recruiting·CCaliway Biopharmaceuticals Co., Ltd.·Phase 2·NCT06303570·20 enrolled
Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride
Recruiting·WWest Virginia University·Phase 1/2·NCT06820164·20 enrolled
A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
Completed·CCaliway Biopharmaceuticals Co., Ltd.·Phase 2·NCT05387733·12 enrolled
Phase 2 Study for the Treatment of Superficial Lipomas
Completed·KKythera Biopharmaceuticals·Phase 2·NCT00608842·62 enrolled
RZL-012 for Dercum's Disease Lipomas
Completed·RRaziel Therapeutics Ltd.·Phase 2·NCT04229030·38 enrolled
Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma
Completed·—·Phase 2·NCT02249052·19 enrolled
A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma
Completed·—·Phase 2·NCT01613313·14 enrolled
Deoxycholic Acid Injection for the Treatment of Superficial Lipomas
Completed·KKythera Biopharmaceuticals·Phase 1·NCT00422188·16 enrolled
Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas
Completed·PPennington Biomedical Research Center·Phase 1/2·NCT00624416·10 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)